We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. PTBP1 protects Y RNA from cleavage leading to its apoptosis-specific degradation

    Some RNAs such as 28S rRNA, U1 small nuclear RNA (snRNA), and Y RNAs are known to be cleaved during apoptosis. The underlying mechanism, functions,...

    Takeshi Kamakura, Kazuaki Kameda, ... Ai Kotani in Cell Death Discovery
    Article Open access 12 July 2024
  2. Polycomb function in early mouse development

    Epigenetic factors are crucial for ensuring proper chromatin dynamics during the initial stages of embryo development. Among these factors, the...

    Livia Condemi, Ivano Mocavini, ... Luciano Di Croce in Cell Death & Differentiation
    Article 12 July 2024
  3. N6-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor

    Background

    The potential involvement of circular RNAs (circRNAs) and N 6 -methyladenosine (m 6 A) modification in the progression of Wilms tumor (WT) has...

    Guannan Shu, Zhang Zhao, ... Guochang Liu in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  4. YTH domain family protein 3 accelerates non-small cell lung cancer immune evasion through targeting CD8+ T lymphocytes

    Immune evasion is one of the critical hallmarks of malignant tumors, especially non-small cell lung cancer (NSCLC). Emerging findings have...

    Yisheng Luo, Chao Zeng, ... Hao Wu in Cell Death Discovery
    Article Open access 11 July 2024
  5. Dexmedetomidine and argon in combination against ferroptosis through tackling TXNIP-mediated oxidative stress in DCD porcine livers

    Graft availability from donation after circulatory death (DCD) is significantly limited by ischaemia reperfusion (IR) injury. Effective strategies to...

    Qian Chen, Jiashi Sun, ... Daqing Ma in Cell Death Discovery
    Article Open access 11 July 2024
  6. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

    Background

    Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in...

    Prachi Bajpai, Sumit Agarwal, ... Upender Manne in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  7. Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously

    Background

    Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the...

    Wen Luo, Hai Hoang, ... Mitchell S. Cairo in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  8. Advancing stroke recovery: unlocking the potential of cellular dynamics in stroke recovery

    Stroke stands as a predominant cause of mortality and morbidity worldwide, and there is a pressing need for effective therapies to improve outcomes...

    Keivan Sahebi, Hassan Foroozand, ... Amir Savardashtaki in Cell Death Discovery
    Article Open access 11 July 2024
  9. Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients

    Fanconi anemia (FA) is a rare hereditary disease resulting from an inactivating mutation in the FA/BRCA pathway, critical for the effective repair of...

    Anne M. van Harten, Ronak Shah, ... Ruud H. Brakenhoff in Oncogenesis
    Article Open access 11 July 2024
  10. Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells

    Cuproptosis is characterized by the aggregation of lipoylated enzymes of the tricarboxylic acid cycle and subsequent loss of iron-sulfur cluster...

    Yuan-Tong Liu, Lei Chen, ... Zhi-Jun Sun in Cell Death & Differentiation
    Article 10 July 2024
  11. Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions

    Cancer immunotherapy harnesses the body’s immune system to combat malignancies, building upon an understanding of tumor immunosurveillance and immune...

    Yan Zhong, **gfeng Liu in Cell Death Discovery
    Article Open access 10 July 2024
  12. The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies

    Pyroptosis is a cell death process characterized by cell swelling until membrane rupture and release of intracellular contents. As an effective tumor...

    Mengyuan Hu, Fengying Deng, ... Fei Yan in Journal of Experimental & Clinical Cancer Research
    Article Open access 10 July 2024
  13. IDH1-mutant metabolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT

    The heterogeneous molecular subtypes of gliomas demonstrate varied responses to chemotherapy and distinct prognostic outcomes. Gliomas with...

    Shuangmei Tong, Jian Wu, ... Bin Wang in Cell Death Discovery
    Article Open access 09 July 2024
  14. Involvement of Kindlin-1 in cutaneous squamous cell carcinoma

    Kindler syndrome (KS) is a rare genodermatosis resulting from loss-of-function mutations in FERMT1 , the gene that encodes Kindlin-1. KS patients have...

    Giovana Carrasco, Ifigeneia Stavrou, ... Valerie G. Brunton in Oncogenesis
    Article Open access 09 July 2024
  15. The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis

    Temozolomide (TMZ) is widely utilized as the primary chemotherapeutic intervention for glioblastoma. However, the clinical use of TMZ is limited by...

    Wenpeng Zhao, Liwei Zhou, ... Zhanxiang Wang in Cell Death Discovery
    Article Open access 08 July 2024
  16. Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma

    Background

    Distinguishing benign from malignant pancreaticobiliary disease is challenging because of the absence of reliable biomarkers. Circulating...

    Daniel S.K. Liu, Jisce R. Puik, ... Adam E. Frampton in Journal of Experimental & Clinical Cancer Research
    Article Open access 08 July 2024
  17. Inhibition of PKC-δ retards kidney fibrosis via inhibiting cGAS-STING signaling pathway in mice

    Kidney fibrosis is considered to be the ultimate aggregation pathway of chronic kidney disease (CKD), but its underlying mechanism remains elusive....

    Dongyun Wang, Yue Li, ... Yonghong Shi in Cell Death Discovery
    Article Open access 07 July 2024
  18. GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma

    Despite significantly improved clinical outcomes in EGFR-mutant lung adenocarcinoma, all patients develop acquired resistance and malignancy on the...

    Ning-xiang Shen, Ming-yu Luo, ... Ying Shen in Oncogene
    Article 05 July 2024
Did you find what you were looking for? Share feedback.